Affymax Says It Didn't Mislead Investors About Anemia Drug
Affymax Inc. urged a California federal judge to toss a proposed shareholder class action over its agreement to supply Fresenius Medical Care with anemia drug Omontys before the medication was recalled,...To view the full article, register now.
Already a subscriber? Click here to view full article